FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
A new research report from Colliers finds that the role of retail pharmacies has changed over time, moving far beyond roles ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.
17hon MSN
The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...
The FTC claims that the prices of some specialty drugs used to treat conditions such as cancer or HIV are being marked up as ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs by $7.3 billion over six years.
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer and HIV treatments between 2017-2022.
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback